Abstract
Genetic and environmental interactions determine cancer risks but some cancer incidence is primarily a result of inherited genetic deficits alone. Most cancers have an occupational, viral, nutritional, behavioral or iatrogenic etiology. Cancer can sometimes be controlled through broad public health interventions including industrial hygiene and engineering controls. Chromium and nickel are two human carcinogens associated with industrial exposures where public health measures apparently work. Carcinogenic mechanisms of these metals are examined by electron-spin-resonance-spectroscopy and somatic-mutation-and-recombination in Drosophila melanogaster in this report. Both metals primarily affect initiation processes in cancer development suggesting important theoretical approaches to prevention and followup.
Similar content being viewed by others
References
Boveri T: The Origin of Malignant Tumors, trans. M. Boveri. Williams and Wilkins, Baltimore, 1929
Berenblum I, Shubik P: A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br J Cancer 1: 383–392, 1947
Nordling CE: A new theory on the cancer inducing mechanism. Br J Cancer 7: 68, 1953
Armitage P, Doll R: The age distribution of cancer and a multistage theory of carcinogenesis. Br J Cancer 8: 1–12, 1954
Foulds L: The natural history of cancer. J Chrn Dis 8: 2–37, 1958
Nowell PC: The clonal evolution of tumor cell populations. Sci 194: 23–28, 1976
Farber E, Cameron R: The sequential analysis of cancer development. Adv Cancer Res 35: 125–226, 1980
Farber E: The multistep nature of cancer development. Cancer Res 44: 4217–4223, 1984
Nowell PC: Mechanisms of tumor progression. Cancer Res 46: 2203–2207, 1986
Yuspa H, Poirier MC: Chemical carcinogenesis: From animal models to molecular models in one decade. Adv Cancer Res 50: 25–70, 1988
Fraumeni JF Jr: Genes and the environment in cancer etiology. In: S. Wilson, L. Jones, C. Coussens, K. Hanna (eds). Cancer and the Environment, Gene-Environment Interactions. National Academy Press, Washington, DC, 2002, pp 14–24
Pott P: Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures, and the Mortification of the Toes and Feet. Hawes, Clark and Collins, London, 1775, pp 7–13, 1775 (reprinted in Natl Inst Monog 10: 7–13, 1963)
Gustavsson P, Gustavsson A, Hogstedt C: Excess of cancer in Swedish chimney sweeps. Brit J Ind Med 45: 777–781, 1988
IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickle and Welding, Vol. 49. IARC, Lyon, France, 1990, pp 389–401
Peto R: Epidemiology, multistage models, and short term mutagenicity tests. In: H.H. Hyatt, J.D. Watson, J.A. Winsten (eds). Origins of Human Cancer. Cold Spring Harbor, NY, 1977, pp 1403–1428
Fernandez-Lopez JA, Esteve M, Rafecas I, Remesar X, Alemany M: Management of dietary essential metals (iron, copper, zinc, chromium and manganese) by Wistar and Zucker obese rats fed on a self-selected high-energy diet. Biometals 7: 117–129, 1994
Kerger BD, Paustenbach DJ, Corbett GE, Finley BL: Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol Appl Pharmacol 141: 145–158, 1996
Weigand HJ, Ottenwalder H, Bolt, HM: Fast uptake kinetics in vitro of 51Cr6+ by red blood cells of man and rat. Arch Toxicol 57: 31–34, 1985
Buttner B, Beyersmann D: Modification of the erythrocyte anion carrier by chromate. Xenobiotica 15: 735–742, 1985
Standeven AM, Wetterhahn KE: Modification of the erythrocyte anion carrier by chromate. J Am Coll Toxicol 8: 1275–1283, 1989
Jennette KW: Microsomal reduction of the carcinogen chromate produces chromium (V). J Am Chem Soc 108: 874–875, 1982
Tsapakos MJ, Wetterhahn KE: The interaction of chromium with nucleic acid. Chem Biol Interact 46: 265–277, 1983
Cupo DY, Wetterhahn KE: Modification of Cr(VI)induced DNA damage by glutathione and cytochrome P-450 in chicken embryo hepatocytes. Proc Natl Acad Sci USA 82: 6755–6759, 1985
Kitagawa S, Seki H, Kametani F, Sakurai H: Uptake of hexavalent chromium by bovine erythrocytes and its interaction with cytoplasmic components: The role of glutathione. Chem Biol Interact 40: 265–274, 1982
Petrilli FL, DeFlora S: Metabolic deactivation of hexavalent chromium mutagenicity. Mutat Res 54: 139–147, 1978
Sugiyama M: Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Rad Biol Med 12: 397–407, 1992
O'Flaherty, EJ: A physiologically-based model of chromium kinetics in the rat. Toxicol Appl Pharmacol 138: 54–64, 1996
Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn KE: Reaction of chromium(V) with hydrogen peroxide in the presence of glutathione; reactive intermediates and resulting DNA damage. Chem Res Toxicol 3: 595–603, 1990
Aiyar J, Borges KM, Floyd RA, Wetterhahn KE: Role of chromium(V) glutathione thiyl radical and hydroxyl radical intermediates in chromium(VI)-induced DNA damage. Toxicol Envirn Chem 22: 135–148, 1990
Shi XL, Dalal NS: On the mechanism of chromate reduction by glutathione: ESR evidence for the glutathionyl radical and an isolatable Cr(V) intermediate. Biochem Biophys Res Commun 156: 137–142, 1988
Shi XL, Dalal NS: Chromium(V) and hydroxyl radical formation during the glutathione reductase catalyzed reduction of chromium(VI). Biochem Biophys Res Commun 163: 627–634, 1989
Shi XL, Dalal NS: On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated Cr(V) species. Arch Biochem Biophys 277: 342–350, 1989
Shi XL, Dalal NS: Evidence for a Fenton-type mechanism for the generation of ·OH radicals in the reduction of Cr(VI) in cellular media. Arch Biochem Biophys 281: 90–95, 1990
Shi XL, Dalal NS: NADPH dependent flavoenzyme catalyzed one electron reduction of metal ions, molecular oxygen and generate hydroxyl radicals. FEBS Lett 276: 189–191, 1990
Shi XL, Dalal NS: ESR spin trapping detection of hydroxyl radicals in the reactions of Cr(V) complexes with hydrogen peroxide. Free Radical Res Commun 10: 17–26, 1990
Szakmary A, Huang Shu-Mei, Chang DT, Beachy PA, Sander M: Overexpression of a Rrp1 transgene reduces the somatic mutation and recombination frequency induced by oxidative DNA damage in Drosophila melanogaster. Proc Natl Acad Sci USA 93: 1607–1612, 1996
Shi, XL, Dalal N: Generation of hydroxyl radical by chromate in biologically relevant systems; role of Cr(V) complexes vs. tetraperoxochromate(V). Environ Health Perspect 102(suppl 3): 231–236, 1994
Shi XL, Dalal NS, Kasprzak KS: Generation of free radicals from hydrogen peroxide and lipid peroxides in the presence of Cr3+. Arch Biochem Biophys 302: 294–299, 1993
Shi XL, Dong ZA, Dalal NS, Gannett PM: Chromate mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid peroxides. Biochim Biophys Acta 1226: 65–74, 1994
Shi XL, Mao Y, Knaptor AD, Ding M, Rojanasakul Y, Gannett PM, Dalal NS, Liu KJ: Reaction of Cr6+ with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of a Cr4+ mediated Fenton-like reaction. Carcinogenesis 15: 2475–2478, 1994
Shi XL, Sun XO, Gannett PM, Dalal NS: Deferoxamine inhibition of Cr5+ mediated radical generation and deoxyguanine hydroxylation: ESR and HPLC evidence. Arch Biochem Biophys 293: 281–286, 1992
Miller EC: Some current perspectives on chemical carcinogenesis in humans and experimental animals: A presidential address. Cancer Res 38: 1479–1496, 1978
Miller EC, Miller JA: Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47: 2327–2345, 1981
Meister A, Anderson ME: Glutathione. Ann Rev Biochem 52: 711–760, 1983
Ames BN, McCann J, Yamasaki E: Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31: 347–364, 1975
Bianchi V, Celott L, Lanfranchi G, Majone F, Marin G, Montaldi A, Sponza G, Tamino, Venier P, Zantedeschi A, Levis AG: Genetic effects of chromium compounds. Mutat Res 117: 279–300, 1983
Petrilli FL, DeFlora S: Toxicity and mutagenicity of hexavalent chromium in Salmonella typhimurium. Appl Environ Microbiol 33: 805–809, 1977
Petrilli FL, DeFlora S: Oxidation of inactive trivalent chromium to the mutagenic hexavalent form. Mutat Res 58: 167–178, 1978
Lindsley Dan L: The genome of Drosophila melanogaster. Academic Press, 1992, pp 1–1134
Davis PS, Shen MW, Judd BH: Asymmetric pairings of transposons in and proximal to the white locus of Drosophila account for 4 classes of regularly occurring exchange products. Proc Natl Acad Sci USA 84: 174–178, 1987
Frei H, Würgler FE: Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases in the wing spot test of Drosophila melanogaster. Mutagenesis 11: 315–325, 1996
Graf U, Würgler FE: The somatic white-ivory eye spot test does not detect the same spectrum of genotoxic events as the wing somatic mutation and recombination test in Drosophila melanogaster. Environ Mol Mutagen 27: 219–226, 1996
Graf U, Frei H, Kagi A, Katz AJ, Würgler FE: Thirty compounds tested in the Drosophila wing spot test. Mutat Res 22: 359–373, 1989
Graf U, Würgler FE, Katz AJ, Frei H, Juon H, Hall CB, Kale PG: Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen 6: 153–188, 1984
Graf U, Würgler FE: The somatic white-ivory eye spot test does not detect the same spectrum of genotoxic events as the wing somatic mutation and recombination test in Drosophila melanogaster. Environ Mol Mutagen 27: 219–226, 1996
Guzman-Rinconl J, Graf U: Drosophila melanogaster somatic mutation and recombination test as a biomonitor. In: F.M. Butterworth (ed). Biomonitor and Biomarkers as Indicators of Environmental Change. Plenum Press, New York, 1995, pp 267–274
Vogel EW, Nivard JM: Performance of 181 chemicals in Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Mutagenesis 8: 57–81, 1993
Vogel EW, Zijlstra JA: Mechanistic and methodological aspects of chemically-induced somatic mutation and recombination in D. melanogaster. Mutat Res 182: 243–264, 1987
Vogel EW, Zijlstra JA: Somatic cell mutagenesis in D. melanogaster in comparison with genetic damage in early germ-cell stages. Mutat Res 180: 189–200, 1987
Würgler FE, Vogel EW: In vivo mutagenicity testing using somatic cells of D. melanogaster (review). In: F. de Serres (ed). Chemical Mutagens. Plenum Press, New York, 1986, 10: 1–59.
Spano MA, Rincon JG, Abraham SK, Andrade HH: The wing somatic mutation and recombination test (SMART) in Drosophila melanogaster: An efficient tool for the detection of genototoxic activity of pure compounds or complex mixtures as well as for studies on antigenotoxicity. African Newsletter on Occ Health and Safety 6(suppl 1): 9–13, 1996
Szakmary A, Huang Shu-Mei, Chang DT, Beachy PA, Sander M: Overexpression of a Rrp1 transgene reduces the somatic mutation and recombination frequency induced by oxidative DNA damage in Drosophila melanogaster. Proc Natl Acad Sci USA 93: 1607–1612, 1996
Kastenbaum MA, Bowman KO: Tables for determining the statistical significance of mutation frequencies. Mutat Res 123: 183–279, 1970
Chiu A, Chiu N, Shi XL, Beaubier J, Dalal NS: Activation of a procarcinogen by reduction: Cr6+ → Cr5+ → Cr4+ → Cr3+: A case study by electron spin resonance spectroscopy ESR/PMR. Env Carc Ecotox Rev 16: 135–148, 1998
Katz AJ, Chiu A, Beaubier J, Shi XL: Combining Drosophila melanogaster somatic-mutation-recombination and electron-spin-resonance-spectroscopy data to interpret epidemiologic observations on chromium carcinogenicity. Mol Cell Biochem 222: 61–68, 2001
Liu KJ, Jiang JJ, Shi XL, Gabrys H, Wakczaj T, Swartz HM: Low frequency EPR study of Cr(V) formation from Cr(VI) in living plants. Biochem Biophys Res Commun 206: 829–834, 1995
Liu KJ, Jiang JJ, Swartz HM, Shi XL: Low frequency EPR detection of chromium(V) formation by chromium(VI) reduction in whole live mice. Arch Biochem Biophys 313: 248–253, 1995
Liu KJ, Shi XL, Jiang JJ, Goda F, Dalal NS, Swartz HM: Chromate induced Cr(V) formation in live mice and its control by cellular antioxidants, an L-band EPR study. Arch Biochem Biophys 323: 33–39, 1995
Liu KJ, Shi XL, Jiang JJ, Goda F, Dalal NS, Swartz HM: Low frequency electron paramagnetic resonance investigation on metabolism of Cr6+ by whole live mice. Ann Clin Lab Sci 26: 176–184, 1996
Liu KJ, Shi XL, Dalal NS: Synthesis of Cr4+-GSH, its identification and its free hydroxyl radical generation: A model compound for Cr6+ carcinogenicity. Biochem Biophys Res Commun 235: 54–58, 1997
Liu KJ, Shi XL: In vivo reduction of chromium(VI) and its free radical generation. Mol Cell Biochem 222: 41–47, 2001
Gaggelli E, Berti F, D'Amelio N, Gaggelli N, Valensin G, Bovalini L, Paffetti A, Trabalzini L: Metabolic pathways of carcinogenic chromium. Env Health Persp 110(suppl 5): 733–738, 2002
Sugden K, Martin BD: Guanine and 7,8-dihydro-8-oxo-guanine-specific oxidation in DNA by chromium(V). Environ Health Perspect 110(suppl 5): 725–728, 2002
Sunderman FW Jr: Carcinogenicity of nickel compounds in animals. In: F.W. Sundermann (ed). Nickel in the Human Environment. IARC Scientific Publications, Lyon, France, 1984, 53: 127–142
Suderman FW Jr, McCully KS: Carcinogenesis tests of nickel arsenides, nickel antimonide, and nickel telluride in rats. Cancer Invest 1: 469–474, 1983
Oller AR: Respiratory carcinogenicity assessment of soluble nickel compounds. Environ Health Perspect 110(suppl 5): 841–844, 2002
Kawanishi S, Oikawa S, Inoue S, Nishino K: Distinct mechanisms of oxidative DNA damage induced by carcinogenic nickel subsulfide and nickel oxides. Environ Health Perspect 110(suppl 5): 789–791, 2002
Klein CB, Frenkel K, Costa M: The role of oxidative processes in metal carcinogenesis. Chem Res Toxicol 4: 592–604, 1991
Klein CB, Costa M: DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 386: 163–180, 1997
Broday L, Peng W, Kuo MH, Salnikov K, Zoroddu M, Costa M: Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res 60: 238–241, 2000
Costa M, Sutherland JE, Peng W, Salnikow K, Broday L, Kluz T: Molecular biology of nickel carcinogenesis. Mol Cell Biochem 222: 205–211, 2001
Wedrychowski A, Ward WS, Schmidt WN, Hnilica LS: Chromium-induced cross-linking of nuclear proteins and DNA. J Biol Chem 260: 7150–7155, 1985
Liyanage M, Colemen A, du Manoir S, McCormack S, Didkson RB, Wynshaw-Boris A, Janz Wienberg J, Ferguson-Smith MA, Schroke E, Ried T: Multicolor spectral karyotyping of mouse chromosomes. Nat Genet 14: 312–315, 1996
Nasmyth K: Separating sister chromatids. Trends Biochem Sci 24: 98–104, 1999
Michaelis C, Ciosk R, Nasmyth K: Cohesins: Chromosomal proteins that prevent premature separation of sister chromatids. Cell 91: 35–45, 1997
Uhlmann F, Nasmyth K: Cohesion between sister chromatids must be established during DNA replication. Genes Dev 8: 1095–1101, 1998
Cremer T, Lichter P, Borden J, Ward DC, Manuelidie L: Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet 80: 235–246, 1988
Speicher MR, Ballard SG, Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12: 368–375, 1996
Paques F, Haber JE: Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63: 349–404, 1999
Sung P, Trujillo KM, Van Komen S: Recombination factors of Saccharomyces cerevisiae. Mutat Res 451: 257–275, 2000
Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J: BASC, a super complex of BRCA1, associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927–939, 2000
Tsuda H, Kato K: Chromosomal aberrations and morphological transformation in hamster embryonic cells treated with potassium dichromate in vitro. Mutat Res 46: 87–94, 1977
Craf E, JR Mahoney, RG Bryant, Eaton JW: Iron catalyzed hydroxyl radical formation stringent requirement for free iron coordination site. J Biol Chem 259: 3620–3624, 1984
Wetterhahn KE, Cupo DY, Connett PH: Metal carcinogens: Metabolism and interaction with protein and DNA. Trace Subst Environ Health 18: 154–162, 1984
Hamilton JW, Wetterhahn KE: Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI) induced DNA damage. Mol Carcinogen 2: 274–286, 1989
Kasprzak KS: The role of oxidative damage in metal carcinogenesis Chem Res Toxicol 4: 604–615, 1991
Ye JP, Zhang XY, Young HA, Mao Y, Shi XL: Cr6+ Induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16: 2401–2420, 1995
Furono K, Suetsuga T, Sugihara N: Effects of metal ions on lipid peroxidation in cultured rat hepatocytes loaded with α-linolenic acid. J Toxicol Environ Health 48: 121–129, 1996
Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511–1517, 1996
Chen F, Ye JP, Zhang XY, Rojanasakul Y, Shi XL: One-electron reduction of Cr6+ by α-lipoic acid and related hydroxyl radical generation, dG hydroxylation and nuclear transcription factor-κB activation. Arch Biochem Biophys 338: 165–172, 1997
Hopfnr KP, Karcher A, Craig L, Woo TT, Carney JP, Tainer JA: Structural biochemistry, and interaction architecture of the DNA double strand break repair Mre11 nuclease and rad 50 ATPase. Cell 105: 473–485, 2001
Hopfner KP, Craig L, Zinkle RA, Usui T, Owen BA, Karcher A, Henderson B, Bodmer JL, McMurray CT, Carney JP, Petrini JHJ, Tainer JA: The rad50 zinc hook is a structure joining MRE11 complex in DNA recombination and repair. Nature 418: 562–566, 2002
D'Amours D, Jackson JP: The MRE11 complex: At the crossroads of DNA repair and checkpoint signaling. Nature Rev Mol Cell Biol 3: 317–325, 2002
Knudson AG: A two-mutation model for human cancer. Adv Viral Oncol 7: 1–17, 1987
Cavenee WK, White RL: The genetic basis of cancer. Sci Am 272: 72–79, 1995
Sengstag C: The role of mitotic recombination in carcinogenesis. Crit Rev Toxicol 24: 323–353, 1994
Shamms MA, Reis RJS: Recombination and its role in DNA repair, cellular immortalization and cancer. Age 22: 71–88, 1999
Tischfield JA: Loss of heterozygosity or: How I learned to stop worrying and love mitotic recombination. Am J Hum Genet 61: 995–999, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiu, A., Katz, A., Beaubier, J. et al. Genetic and cellular mechanisms in chromium and nickel carcinogenesis considering epidemiologic findings. Mol Cell Biochem 255, 181–194 (2004). https://doi.org/10.1023/B:MCBI.0000007274.25052.82
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000007274.25052.82